Shire Plc (SHPG)

160.05
1.70 1.05
NASDAQ : Health Technology
Prev Close 161.75
Open 158.96
Day Low/High 158.50 / 160.43
52 Wk Low/High 123.73 / 177.51
Volume 794.62K
Avg Volume 1.48M
Exchange NASDAQ
Shares Outstanding 300.99M
Market Cap 49.59B
EPS 14.30
P/E Ratio 44.23
Div & Yield 1.05 (0.65%)

Latest News

SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Shire Plc And Encourages Investors To Contact The Firm For Additional Information

SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Shire Plc And Encourages Investors To Contact The Firm For Additional Information

The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of Shire plc (Nasdaq: SHPG) ("Shire" or the...

Dow Trims Earlier Losses, Finishes Slightly Higher After Volatile Session

Dow Trims Earlier Losses, Finishes Slightly Higher After Volatile Session

Stocks finished mixed on Tuesday after President Trump announced that the U.S. would withdraw from the Iran nuclear deal.

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors Of An Investigation Regarding Whether The Sale Of Shire Plc To Takeda Pharmaceutical Company Limited Is Fair To Shareholders

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors Of An Investigation Regarding Whether The Sale Of Shire Plc To Takeda Pharmaceutical Company Limited Is Fair To Shareholders

The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who purchased Shire plc ("Shire" or the "Company") (NASDAQGS: SHPG) stock  prior to May 8, 2018 .

Global Stocks Mixed, Dollar Surging as Markets Await Trump Decision on Iran

Global Stocks Mixed, Dollar Surging as Markets Await Trump Decision on Iran

Oil pulled back from three-and-a-half year highs in overnight trading as markets await President Donald Trump's decision on renewed Iran sanctions that could pull a further 500,000 barrels of oil from the market each day.

Musk Buys 33,000 More Tesla Shares and 4 Other Stories You Must Know Tuesday

Musk Buys 33,000 More Tesla Shares and 4 Other Stories You Must Know Tuesday

Here's what you need to know as futures point lower heading into the open.

Takeda Pharmaceutical Agrees $62.4 Billion Takeover of Shire

Takeda Pharmaceutical Agrees $62.4 Billion Takeover of Shire

Japan's biggest drugmaker, Takeda Pharmaceutical Co., looks to have wrapped up its bid to buy Dublin-based Shire plc for $62.4 billion in cash and shares.

Surveying the M&A Landscape in Biotech

Surveying the M&A Landscape in Biotech

Who might be in play in the quarters ahead?

Sprint/T-Mobile Deal Shows M&A Is Firing Up

Sprint/T-Mobile Deal Shows M&A Is Firing Up

Companies have lots of repatriated cash to use on purchases.

Dow and S&P 500 Finish Higher Amid Strong Corporate Earnings

Dow and S&P 500 Finish Higher Amid Strong Corporate Earnings

Stocks rise after stronger-than-expected earnings from Boeing and Twitter.

First-Quarter Earnings Highlights

First-Quarter Earnings Highlights

Homebuilders and industrial names are seeing good results.

Daily Chatter: Here's Where the Markets Stand After Tuesday's Beating

Daily Chatter: Here's Where the Markets Stand After Tuesday's Beating

Global stocks are on the defensive Wednesday, pulling U.S. futures and European shares lower, as investor re-set expectations for corporate profits in the face of rising investment and input costs.

Dow Futures Turn Positive After Boeing Earnings Blowout; Twitter Boosts Nasdaq

Dow Futures Turn Positive After Boeing Earnings Blowout; Twitter Boosts Nasdaq

U.S. stocks attempted to reverse the global tide Wednesday, with futures improving after better-than-expected earnings from Boeing and Twitter and a spate of multi-billion merger deals at home and abroad.

Facebook, Boeing, Shire and Credit Suisse - 5 Things You Must Know

Facebook, Boeing, Shire and Credit Suisse - 5 Things You Must Know

U.S. stock futures point to further losses for Wall Street and global stocks slump on Wednesday; Facebook, Boeing and AMD report earnings; Takeda sweetens offer for Shire.

Facebook Prepares for Earnings and 4 Other Stories You Must Know Wednesday

Facebook Prepares for Earnings and 4 Other Stories You Must Know Wednesday

As Wall Street prepares for another rough day, these are the business stories you must know.

The Global Stock Market Rout Spreads Across the World

The Global Stock Market Rout Spreads Across the World

Global stocks are on the defensive Wednesday, pulling U.S. futures and European shares lower, as investor re-set expectations for corporate profits in the face of rising investment and input costs.

Closing Bell: LIVE MARKETS BLOG

Closing Bell: LIVE MARKETS BLOG

The Dow fell triple digits after starting the day off in the green.

Here's My Take on Biotech Stocks

Here's My Take on Biotech Stocks

I think M&A activity will pick up markedly going forward across the industry.

Some Biotech Stocks to Add Exposure To

Some Biotech Stocks to Add Exposure To

Secondary offerings create buying opportunities.

Three Biotech Names to Consider

Three Biotech Names to Consider

A look at three names to consider in the biotech and biopharma space.

Dow Jumps 212 Points as Wall Street Shrugs Off Syria and Turns to Earnings

Dow Jumps 212 Points as Wall Street Shrugs Off Syria and Turns to Earnings

Stocks rise Monday as concerns over prolonged military action in Syria fade and the focus for investors shifts to a heavy upcoming slate of U.S. corporate earnings.

Watch Oncology Stocks Ahead of 2 Big Events

Watch Oncology Stocks Ahead of 2 Big Events

Data and industry conferences will likely be catalysts for shares in the space.

Global Stocks Mixed, Wall Street Steady as Syria Strikes Keep Investors on Edge

Global Stocks Mixed, Wall Street Steady as Syria Strikes Keep Investors on Edge

U.S. equity futures gave back earlier gains Monday even as investor concern over prolonged military action in Syria faded following weekend missile strikes in reaction to an alleged chemicals weapons attack last week in the city of Douma.

Shire Plans $2.4 Billion Oncology Business Sale to France's Servier SAS

Shire Plans $2.4 Billion Oncology Business Sale to France's Servier SAS

Shire will sell its oncology business to France's Servier for around $2.4 billion as it contemplates a possible $50 billion takeover from Japan's Takeda Pharmaceutical Co.

U.S. Futures Up, Global Markets Mixed on Geopolitical Tension

U.S. Futures Up, Global Markets Mixed on Geopolitical Tension

Oil remained near a three-year high despite falling back slightly on Thursday.

Dow, S&P Suffer Worst Day of Trading in 2 Weeks

Dow, S&P Suffer Worst Day of Trading in 2 Weeks

China on Friday said it would counter Trump's proposed new tariffs 'to the end, and at any cost'

Global Stocks, Wall Street Futures Up as Trade Worries Ease

Global Stocks, Wall Street Futures Up as Trade Worries Ease

Wall Street is also expected to start the day in positive territory on Thursday after tumultuous trading on Wednesday.

Second Quarter Predictions

Second Quarter Predictions

Better-than-expected earnings will help soothe market jitters in the second quarter.

If Stocks Don't Pop on All This Deals News Investors Better Look Out Below

If Stocks Don't Pop on All This Deals News Investors Better Look Out Below

M&A activity kicks into high gear going into the final days of the first quarter. If the broader stock market doesn't pop on this news, it would be a red flag.

TheStreet Quant Rating: C (Hold)